Treatment Of Melanoma With Ferroptosis Inducing Agents

Researchers at UCLA have developed a method to treat melanoma that resists conventional immune checkpoint blockade immunotherapy by using ferroptosis-inducing drugs. Ferroptosis is a type of cell death resulting from accumulation of reactive oxygen spe…

Researchers at UCLA have developed a method to treat melanoma that resists conventional immune checkpoint blockade immunotherapy by using ferroptosis-inducing drugs. Ferroptosis is a type of cell death resulting from the accumulation of reactive oxygen species that degrade lipids in the cell membrane. De-differentiating cells, such as immunotherapy-resistant or kinase inhibitor-resistant melanoma, are highly susceptible to ferroptosis. Combination treatment with ferroptosis-inducing agents can be a valuable, new synergistic approach for overcoming resistance to melanoma therapy.

Abstract

Researchers in the Department of Physics have developed a method for detecting localized electrical breakdowns in high-power RF networks.

Website

https://techtransfer.universityofcalifornia.edu/NCD/28908.html?utm_source=AUTMGTP&utm_medium=webpage&utm_term=ncdid_28908&utm_campaign=TechWebsites

Advantages

  • Early detection
  • Does not require taking the system apart 
  • No additional components required
  • Detection in complex waveguides

Potential Applications

  • Transmission lines
  • Radar systems
  • Electrical protective systems
  • High-frequency protective circuits

Contact Information

Name: UCLA Technology Development Group

Email: ncd@tdg.ucla.edu

Phone: 310.794.0558